ADAMTS-13 levels in fresh, stored, and solvent detergent treated plasma

Transfusion and Apheresis Science

Volumn 35, Issue 3, 2006, Pages 235-238

  Rock, G ^a   Yousef, H ^a   Neurath, D ^a   Lu, M ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

ADAMTS 13; Fresh plasma storage; Solvent detergent treated plasma

Indexed keywords

ALBUMIN; FIBRINOGEN; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; PROTEIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; CRYOPRESERVATION; HUMAN; PLASMA; ROOM TEMPERATURE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; BLOOD PRESERVATION; DETERGENTS; HUMANS; PLASMA; SOLVENTS; TEMPERATURE; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 33845222391     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2006.08.006     Document Type: Article

References (15)

1. Fujikawa K., Suzuki H., McMullen B., and Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98 6 (2001) 1662-1666
2. Plaimauer B., Zimmermann K., Volkel D., Antoine G., Kerschbaumer R., Jenab P., et al. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood 100 10 (2002) 3626-3632
3. Furlan M. Von Willebrand factor: molecular size and functional activity. Ann Hematol 72 (1996) 341-348
4. Arya M., Anvari B., Romo G.M., Cruz M.A., Dong J.-F., McIntire L.V., et al. Ultra-large multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet GP Ib-IX complex: studies using optical tweezers. Blood 99 (2002) 3971-3977
5. Dong J.-F., Moake J.L., Nolasco L., Bernardo A., Arceneaux W., Shrimpton C.N., et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 100 (2002) 4033-4039
6. Soejima K., and Nakagaki T. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies. Semin Hematol 42 1 (2005) 56-62
7. Furlan M., Robles R., Solenthaler M., Wassmer M., Sandoz P., Lämmle B., et al. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89 (1997) 3097-3103
8. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the haemolytic uremic syndrome. N Engl J Med 339 (1998) 1578-1584
9. Tsai H.M., and Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 (1998) 1585-1594
10. Furlan M., Robles R., Solenthaler M., and Lämmle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 91 (1998) 2839-2846
11. Rock G.A., Shumak K.H., Buskard N.A., Blanchette V.S., Kelton J.C., Nair R.C., et al. Comparison of plasma exchange with plasma infusion in treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325 (1991) 393-397
12. Furlan M., Robles R., and Lamie B. Partial purification and characterization of protease from human plasma cleaving von Willebrand factor to fragment produced by in vivo proteolysis. Blood 87 (1996) 4223-4234
13. Rick M.E., Austin H., Leitman S.F., Krizek D.M., and Aronson D.L. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS-13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura. Am J Hematol 75 2 (2004) 96-100
14. Tsai H.M. Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes. J Thromb Haemost 1 4 (2003) 625-631
15. Vermeer C., Soute B.A., Ates G., Hellings J.A., and Brummelhuis H.G. Contributions to the optimal use of human blood FVIII. Stability of blood coagulation factor VIII during collection and storage of whole blood and plasma. Vox Sang 31 (1976) 55-67